The many faces of interleukin-6: The role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis

International Journal of Rheumatology

Volumn 2011, Issue , 2011, Pages

  Barnes, Theresa C ^a   Anderson, Marina E ^a   Moots, Robert J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; RITUXIMAB; SOLUBLE INTERLEUKIN 6 RECEPTOR; TOCILIZUMAB; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL SELECTION; CHRONIC INFLAMMATION; DISEASE ACTIVITY; DRUG TARGETING; ENDOTHELIUM CELL; FIBROGENESIS; FIBROSIS; HUMAN; INHIBITION KINETICS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SCORING SYSTEM; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; TH17 CELL; VASCULAR DISEASE;

EID: 81555209757     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2011/721608     Document Type: Review

References (56)

1. Jones S. A., Rose-John S., The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex Biochimica et Biophysica Acta 2002 1592 3 251 263 (Pubitemid 35284882)
2. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., Van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A., Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment Immunity 1997 6 3 315 325 (Pubitemid 27148598)
3. Mullberg J., Schooltink H., Stoyan T., Gunther M., Graeve L., Buse G., Mackiewicz A., Heinrich P. C., Rose-John S., The soluble interleukin-6 receptor is generated by shedding European Journal of Immunology 1993 23 2 473 480 (Pubitemid 23075080)
4. Mullberg J., Schooltink H., Stoyan T., Heinrich P. C., Rose-John S., Protein kinase C activity is rate limiting for shedding of the interleukin 6 receptor Biochemical and Biophysical Research Communications 1992 189 2 794 800 (Pubitemid 23032443)
5. Lust J. A., Donovan K. A., Kline M. P., Greipp P. R., Kyle R. A., Maihle N. J., Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor Cytokine 1992 4 2 96 100
6. Horiuchi S., Koyanagi Y., Zhou Y., Miyamoto H., Tanaka Y., Waki M., Matsumoto A., Yamamoto M., Yamamoto N., Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism European Journal of Immunology 1994 24 8 1945 1948 (Pubitemid 24237574)
7. Marin V., Montero-Julian F. A., Gres S., Bongrnad P., Farnarier C., Kaplanski G., Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloprotease of the TNFalpha converting enzyme (TACE) type European Journal of Immunology 2002 32 2965 2972
8. Furuse S., Fujii H., Kaburagi Y., Fujimoto M., Hasegawa M., Takehara K., Sato S., Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene- are elevated in patients with systemic sclerosis Journal of Rheumatology 2003 30 7 1524 1528 (Pubitemid 36835450)
9. Reitamo S., Remitz A., Varga J., Ceska M., Effenberger F., Jimenez S., Uitto J., Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders Archives of Dermatology 1993 129 2 189 193 (Pubitemid 23063871)
10. Kowal-Bielecka O., Kowal K., Distler O., Rojewska J., Bodzenta-Lukaszyk A., Michel B. A., Gay R. E., Gay S., Sierakowski S., Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators Arthritis and Rheumatism 2005 52 12 3783 3791 (Pubitemid 41798216)
11. Jones S. A., Richards P. J., Scheller J., Rose-John S., IL-6 transsignaling: the in vivo consequences Journal of Interferon and Cytokine Research 2005 25 5 241 253 (Pubitemid 40664421)
12. Kaplanski G., Marin V., Montero-Julian F., Mantovani A., Farnarier C., IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation Trends in Immunology 2003 24 1 25 29 (Pubitemid 35462110)
13. Matsushita T., Hasegawa M., Hamaguchi Y., Takehara K., Sato S., Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis Journal of Rheumatology 2006 33 2 275 284 (Pubitemid 43209303)
14. Sato S., Hasegawa M., Takehara K., Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis Journal of Dermatological Science 2001 27 2 140 146 (Pubitemid 32781022)
15. Feghali C. A., Bost K. L., Boulware D. W., Levy L. S., Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma Journal of Rheumatology 1992 19 8 1207 1211
16. Kadono T., Kikuchi K., Ihn H., Takehara K., Tamaki K., Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts Journal of Rheumatology 1998 25 2 296 301 (Pubitemid 28088258)
17. Giacomelli R., Cipriani P., Danese C., Pizzuto P., Lattanzio R., Parzanese I., Passacantando A., Perego M. A., Tonietti G., Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor 1 Journal of Rheumatology 1996 23 2 294 296 (Pubitemid 126500951)
18. Hasegawa M., Sato S., Fujimoto M., Ihn H., Kikuchi K., Takehara K., Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis Journal of Rheumatology 1998 25 2 308 313 (Pubitemid 28088260)
19. Distler O., Distler J. H. W., Scheid A., Acker T., Hirth A., Rethage J., Michel B. A., Gay R. E., Mller-Ladner U., Matucci-Cerinic M., Plate K. H., Gassmann M., Gay S., Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis Circulation Research 2004 95 1 109 116 (Pubitemid 38931842)
20. Ni C. W., Hsieh H. J., Chao Y. J., Wang D. L., Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow American Journal of PhysiologyCell Physiology 2004 287 3 C771 C780 (Pubitemid 39095864)
21. Bosello S., De Santis M., Lama G., Span C., Angelucci C., Tolusso B., Sica G., Ferraccioli G., B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial Arthritis Research and Therapy 2010 12 2
22. Hurst S. M., Wilkinson T. S., McLoughlin R. M., Jones S., Horiuchi S., Yamamoto N., Rose-John S., Fuller G. M., Topley N., Jones S. A., IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation Immunity 2001 14 6 705 714 (Pubitemid 32592418)
23. McLoughlin R. M., Witowski J., Robson R. L., Wilkinson T. S., Hurst S. M., Williams A. S., Williams J. D., Rose-John S., Jones S. A., Topley N., Interplay between IFN- and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation Journal of Clinical Investigation 2003 112 4 598 607 (Pubitemid 38056344)
24. Afford S. C., Pongracz J., Stockley R. A., Crocker J., Burnett D., The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils Journal of Biological Chemistry 1992 267 30 21612 21616
25. Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A., Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products Blood 1992 80 8 2012 2020
26. Biffl W. L., Moore E. E., Moore F. A., Barnett C. C., Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent Journal of Leukocyte Biology 1995 58 5 582 584
27. Narimatsu M., Maeda H., Itoh S., Atsumi T., Ohtani T., Nishida K., Itoh M., Kamimura D., Park S. J., Mizuno K., Miyazaki J. I., Hibi M., Ishihara K., Nakajima K., Hirano T., Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in t cells Molecular and Cellular Biology 2001 21 19 6615 6625 (Pubitemid 32927428)
28. Teague T. K., Marrack P., Kappler J. W., Vella A. T., IL-6 rescues resting mouse T cells from apoptosis Journal of Immunology 1997 158 12 5791 5796 (Pubitemid 127483985)
29. Curnow S. J., Scheel-Toellner D., Jenkinson W., Raza K., Durrani O. M., Faint J. M., Rauz S., Wloka K., Pilling D., Rose-John S., Buckley C. D., Murray P. I., Salmon M., Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling Journal of Immunology 2004 173 8 5290 5297 (Pubitemid 39387813)
30. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., Akira S., Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell- specific stat3-deficient mice Journal of Immunology 1998 161 9 4652 4660 (Pubitemid 28492039)
31. Koch A. E., Kronfeld-Harrington L. B., Szekanecz Z., Cho M., Haines G. K., Harlow L. A., Strieter R. M., Kunkel S. L., Massa M. C., Barr W. G., Jimenez S. A., In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease Pathobiology 1993 61 5-6 239 246 (Pubitemid 24007481)
32. Atreya R., Mudter J., Finotto S., Blockade of interleukin 6 trans signalling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo Nature Medicine 2000 6 583 588 (Pubitemid 30305911)
33. Green R. M., Whiting J. F., Rosenbluth A. B., Beier D., Gollan J. L., Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium- potassium-adenosinetriphosphatase activity American Journal of Physiology 1994 267 6 G1094 G1100
34. Drakesmith H., O'Neil D., Schneider S. C., Binks M., Medd P., Sercarz E., Beverley P., Chain B., In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen Proceedings of the National Academy of Sciences of the United States of America 1998 95 25 14903 14908 (Pubitemid 29003729)
35. Matzinger P., Graft tolerance: a duel of two signals Nature Medicine 1999 5 6 616 617 (Pubitemid 29289419)
36. Kallen K. J., The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases Biochimica et Biophysica Acta 2002 1592 3 323 343
37. Jones S. A., Horiuchi S., Topley N., Yamamoto N., Fuller G. M., The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB Journal 2001 15 1 43 58 (Pubitemid 32061655)
38. Lissilaa R., Buatois V., Magistrelli G., Williams A. S., Jones G. W., Herren S., Shang L., Malinge P., Guilhot F., Chatel L., Hatterer E., Jones S. A., Kosco-Vilbois M. H., Ferlin W. G., Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity Journal of Immunology 2010 185 9 5512 5521
39. Sgonc R., Gruschwitz M. S., Boeck G., Sepp N., Gruber J., Wick G., Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95 Arthritis and Rheumatism 2000 43 11 2550 2562
40. Worda M., Sgonc R., Dietrich H., Niederegger H., Sundick R. S., Gershwin M. E., Wick G., In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay Arthritis and Rheumatism 2003 48 9 2605 2614 (Pubitemid 37129437)
41. Gabrielli A., Svegliati S., Moroncini G., Avvedimento E. V., Pathogenic autoantibodies in systemic sclerosis Current Opinion in Immunology 2007 19 6 640 645 (Pubitemid 50014683)
42. Strehlow D., Korn J. H., Biology of the scleroderma fibroblast Current Opinion in Rheumatology 1998 10 6 572 578 (Pubitemid 28508752)
43. Mihara M., Moriya Y., Ohsugi Y., IL-6-soluble IL-6 receptor complex inhibits the proliferation of dermal fibroblasts International Journal of Immunopharmacology 1996 18 1 89 94 (Pubitemid 26122640)
44. Duncan M. R., Berman B., Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6 Journal of Investigative Dermatology 1991 97 4 686 692
45. Sprri B., Mller K. M., Wiesmann U., Bickel M., Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts International Immunology 1999 11 7 1053 1058 (Pubitemid 29338746)
46. Mihara M., Moriya Y., Kishimoto T., Ohsugi Y., Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor British Journal of Rheumatology 1995 34 4 321 325
47. Ito A., Itoh Y., Sasaguri Y., Morimatsu M., Mori Y., Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts Arthritis and Rheumatism 1992 35 10 1197 1201
48. Irwin C. R., Myrillas T. T., Traynor P., Leadbetter N., Cawston T. E., The role of soluble interleukin (IL)-6 receptors in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts Journal of Periodontology 2002 73 7 741 747
49. Nakahara H., Song J., Sugimoto M., Hagihara K., Kishimoto T., Yoshizaki K., Nishimoto N., Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis Arthritis and Rheumatism 2003 48 6 1521 1529 (Pubitemid 36682359)
50. Shima Y., Kuwahara Y., Murota H., Kitaba S., Kawai M., Hirano T., Arimitsu J., Narazaki M., Hagihara K., Ogata A., Katayama I., Kawase I., Kishimoto T., Tanaka T., The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab Rheumatology 2010 49 12 2408 2412
51. Fleming J. N., Schwartz S. M., The pathology of scleroderma vascular disease Rheumatic Disease Clinics of North America 2008 34 1 41 55 (Pubitemid 351337630)
52. Nguyen V. A., Sgonc R., Dietrich H., Wick G., Endothelial in jury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma) Journal of Autoimmunity 2000 14 2 143 149 (Pubitemid 30662574)
53. Herrick A. L., Illingworth K., Blann A., Hay C. R. M., Hollis S., Jayson M. I. V., Von Willebrand factor, thrombomodulin, thromboxane, -thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis Annals of the Rheumatic Diseases 1996 55 2 122 127 (Pubitemid 26050121)
54. Blann A. D., Herrick A., Jayson M. I. V., Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis British Journal of Rheumatology 1995 34 9 814 819
55. Gruschwitz M. S., Hornstein O. P., von Den Driesch P., Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity Arthritis and Rheumatism 1995 38 2 184 189
56. Barnes T. C., Spiller D. G., Anderson M. E., Edwards S. W., Moots R. J., Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Annals of the Rheumatic Diseases 2011 70 2 366 372